$LGND Ligand Pharmaceuticals: Carbella CRL Delay No Big Deal Due To Diversified Revenues, Says Roth Capital http://www.smarteranalyst.com/2014/10/27/ligand-pharmaceuticals-carbella-crl-delay-big-deal-due-diversified-revenues-says-roth-capital/